[Experiences with the new antimycotic agent pimaricin].
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D001446:Balanitis / Q000188:drug therapy; D002613:Cheilitis / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D009181:Mycoses / Q000188:drug therapy*; D010866:Natamycin / Q000008:administration & dosage / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D009824:Ointments; D014627:Vaginitis / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D009824:Ointments; D010866:Natamycin; D009355:Neomycin; D006854:Hydrocortisone; D004121:Dimethyl Sulfoxide
Erfahrungen mit einem neuen Antimykotikum, dem Pimaricin.